Özgür Kılınçarslan

Özgür Kılınçarslan

Auto-generated profile, based on publicly available information

Özgür Kılınçarslan

Ege University School of Medicine

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2025 in Journal of Surgical Education
Verified
Journal Article
Closed access
ÖKÖzgün Cevdet Köse
Özgün Cevdet Köse
YTYiğit Türk
Yiğit Türk
SKSevgi Özan Köse
Sevgi Özan Köse
ÖKÖzgür Kılınçarslan
Özgür Kılınçarslan
OVOzan Verendağ
Ozan Verendağ
GIGökhan İçÖz
Gökhan İçÖz

15 March 2024 in Turkish Journal of Gastroenterology
Verified
Journal Article
Open access
VUVEYSEL UMMAN
VEYSEL UMMAN
ÖKÖzgür Kılınçarslan
Özgür Kılınçarslan
RTRecep Temel
Recep Temel
YBYener Bağdat
Yener Bağdat
STSarp Tunalı
Sarp Tunalı
ÖFÖzgür Fırat
Özgür Fırat
Background/Aims: Gastrointestinal stromal tumors (GISTs), the most common mesenchymal tumors in the gastrointestinal tract, are increasingly treated with minimally invasive surgeries. Developed techniques include laparoscopic, endoscopic, and hybrid methods for gastric GIST resection. Our study, focusing on single-incision laparoscopic intragastric resection for gastric GISTs, aims to evaluate its safety, efficacy, and long-term outcomes. Materials and Methods: In a retrospective study of GIST surgery involving 14 patients who underwent single-incision laparoscopic intragastric resections, we analyzed and compared their preoperative demographics, American Society of Anesthesiologists (ASA) scores, tumor size, neoadjuvant treatment, operation duration, hospital stay, mitotic and Ki-67 indexes, and histological features with those of patients who underwent open and laparoscopic wedge resections, to assess the impact on both survival and disease-free survival. Results: Average operation time was 93.07 minutes (range 81-120 minutes). Average blood loss: 67 +- 20 mL (range 40-110 mL). Postoperative hospital stay averaged 6.79 days (range 4-16 days). Strong correlations were observed between preoperative and pathological tumor sizes (P = .001, P < .001). Survival analysis indicated a significant association with ASA scores (P = .031), but not with mitotic index, Ki-67, or tumor size. Average survival was 80.57 months, with no recurrence or metastasis during follow-up. Conclusion: Based on our experience, the single-incision laparoscopic intragastric resection method emerges as a highly efficient, timesaving, and gentle oncological procedure, providing a safe and minimally invasive alternative resulting in shorter hospital stays and excellent long-term outcomes with minimal recurrence. For more definitive conclusions, larger, multicenter, and prospective studies are recommended. Cite this article as: Umman V, KılınÇarslan ö, Temel R, et al. Long-term efficacy of single-incision laparoscopic intragastric resection in treating gastrointestinal stromal tumors. Turk J Gastroenterol. 2024;35(3):193-203.

13 November 2025 in Scottish Medical Journal
Verified
Journal Article
Closed access
ÖKÖzgür Kılınçarslan
Özgür Kılınçarslan
VSVolkan Sayur
Volkan Sayur
EGErkan Güler
Erkan Güler
RTRecep Temel
Recep Temel
ÖKÖzgün Cevdet Köse
Özgün Cevdet Köse
TSTaylan Özgür Sezer
Taylan Özgür Sezer
Background: Peritoneal carcinomatosis (PC) represents an advanced stage of intra-abdominal malignancies with poor prognosis. Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) offers promising outcomes in selected patients. This study evaluated survival and prognostic factors in patients undergoing CRS-HIPEC for malignancy-associated PC. Methods: A retrospective analysis was performed on 116 patients treated with CRS-HIPEC between 2015 and 2023. Data included demographics, tumor origin, peritoneal cancer index (PCI), completeness of cytoreduction (CC) score, complications, and survival outcomes. Kaplan–Meier and Cox regression analyses were used. Results: The mean age was 55.2 years; 61.2% were female. Common primary tumors were colorectal (34.5%), gastric (20.7%), ovarian (17.2%), and appendiceal (16.4%). Mean PCI was 11.9, and complete cytoreduction (CC-0) was achieved in 89.7%. Overall survival was highest in appendiceal (76.9 months) and lowest in gastric cancer (24.7 months). Median disease-free and overall survival were 36 and 43.9 months, respectively. Postoperative complications occurred in 31.8%; mortality was 5.17%. High PCI and incomplete cytoreduction were independently associated with worse survival. Conclusion: CRS-HIPEC provides encouraging survival in selected PC patients, especially with low PCI and complete cytoreduction. Careful patient selection remains key to optimizing outcomes.